| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Puma Biotechnology, Inc. (PBYI) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. PBYI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 227.5K | $1.83M | - | |
| Other | 70.3K | $565.4K | - | |
| CFO | 66.5K | $535.0K | - | |
| Dir | 54.0K | $434.2K | - | |
| Dir | 41.9K | $336.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2019 | Auerbach Alan H62 | President And CEO | Sell | 4,424 | $20.67 | $91,444.08 | -0.1% | |
| Jan 3, 2019 | Eyler Charles R | See Remarks | Sell | 1,210 | $20.67 | $25,010.70 | -3.6% | |
| Jan 3, 2019 | Bryce Richard Paul | See Remarks | Sell | 1,210 | $20.67 | $25,010.70 | -3.7% | |
| Dec 3, 2018 | Eyler Charles R | See Remarks | Sell | 1,239 | $22.77 | $28,212.03 | -3.5% | |
| Jul 20, 2018 | Lo Steven | Chief Commercial Officer | Sell | 1,839 | $51.85 | $95,360.06 | -7.3% | |
| Jul 20, 2018 | Eyler Charles R | See Remarks | Sell | 610 | $51.95 | $31,689.50 | -1.7% | |
| Jul 20, 2018 | Bryce Richard Paul | See Remarks | Sell | 1,836 | $51.95 | $95,381.30 | -5.3% | |
| Jul 20, 2018 | Auerbach Alan H62 | President And CEO | Sell | 12,520 | $52.00 | $651,019.97 | -0.3% | |
| Jun 1, 2018 | Eyler Charles R | See Remarks | Sell | 1,211 | $53.00 | $64,183.00 | -3.3% | |
| Jan 22, 2018 | Lo Steven | Chief Commercial Officer | Sell | 1,858 | $92.85 | $172,515.30 | -6.8% |